Regulatory Affairs Updates
Discover the latest news in Regulatory Affairs
Revision 2 of MDCG 2022-4 on MDR Appropriate surveillance
- Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager
On May 27th, 2024, the Medical Device Coordination Group (MDCG) released a second revision on the guidance on appropriate surveillance regarding the transitional provisions under Article 120 of the MDR with regard to devices covered by certificates according to the MDD or the AIMDD (MDCG 2022-4 Revision 2).
![ra updates 4](https://qbdgroup.com/wp-content/uploads/9-4.jpg)
This second revision includes adjustments all over the document to align it to Regulation (EU) 2023/607 of the European Parliament and of the Council of 15 March 2023 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards the transitional provisions for certain medical devices and in vitro diagnostic medical devices.
Get in touch with our experts
Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.
Did you find this article interesting? Thanks for sharing it with your network:
Subscribe to Regulatory Affairs Update
Here you find all news related to Regulatory Affairs